NEW YORK CITY, NEW YORK / ACCESS Newswire / October 30, 2025 / TruMerit President and CEO Peter Preziosi has been elected President of the Conference of Non-Governmental Organizations in Consultative Relationship with the United Nations, also known as CoNGO.CoNGO | TruMeritConference of Non-Governmental Organizations in Consultative Relationship with the United Nations, also known as […]

(NASDAQ:HNVR), Third Quarter Performance Highlights Net Income: Net income for the quarter ended September 30, 2025 totaled $3.5 million or $0.47 per diluted share (including Series A preferred shares), versus $2.4 million or $0.33 per diluted share (including Series A preferred shares) in the prior linked quarter. Pre-Provision Net Revenue: Pre-provision net revenue was $6.0

(PinkSheets:ALPIB),(Pinksheets:ALPIB), GLENWOOD SPRINGS, Colo., Oct. 30, 2025 (GLOBE NEWSWIRE) — Alpine Banks of Colorado (OTCQX: ALPIB) (“Alpine” or the “Company”), the holding company for Alpine Bank (the “Bank”), today announced results (unaudited) for the third quarter ended September 30, 2025. The Company reported net income of $18.5 million, or $1.16 per basic Class A common

(NASDAQ:BAFN), ST. PETERSBURG, Fla., Oct. 30, 2025 (GLOBE NEWSWIRE) — BayFirst Financial Corp. (NASDAQ: BAFN) (“BayFirst” or “Company”), parent company of BayFirst National Bank (“Bank”) today reported a net loss of $18.9 million, or $4.66 per common share and diluted common share, for the third quarter of 2025, compared to a net loss of $1.2

(NASDAQ:MOLN),(SWX:MOLN.SW), IND application filed for MP0712, the Company's lead Radio-DARPin candidate targeting DLL3 and co-developed with Orano Med, with Phase 1 initiation expected before year end 2025 First patient images from MP0712 compassionate care program to be presented at TRP in November; additional programs planned for 2026, including MP0726 targeting mesothelin. Updated data from Phase

(NASDAQ:NEPH), SOUTH ORANGE, N.J., Oct. 30, 2025 (GLOBE NEWSWIRE) — Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will file its third-quarter financial results on Thursday, November 6, 2025 after market close and will host a conference call that same day

(Paris:GNFT), GENFIT's decision to delist from Nasdaq reflects strategic intent to simplify corporate structure and improve operational efficiency GENFIT remains listed on the regulated market of Euronext Paris as its primary trading market Lille (France), Cambridge (Massachusetts, United States), (Zurich, Switzerland); October 30, 2025 – GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to

Hanover Bancorp, Inc. Reports Third Quarter 2025 Results and Declares $0.10 Quarterly Cash Dividend GlobeNewswire October 30, 2025 Third Quarter Performance Highlights Net Income: Net income for the quarter ended September 30, 2025 totaled $3.5 million or $0.47 per diluted share (including Series A preferred shares), versus $2.4 million or $0.33 per diluted share (including

Alpine Banks of Colorado announces financial results for third quarter 2025 GlobeNewswire October 30, 2025 GLENWOOD SPRINGS, Colo., Oct. 30, 2025 (GLOBE NEWSWIRE) — Alpine Banks of Colorado (OTCQX: ALPIB) (“Alpine” or the “Company”), the holding company for Alpine Bank (the “Bank”), today announced results (unaudited) for the third quarter ended September 30, 2025. The

Molecular Partners Reports Q3 2025 Financial Results and Clinical Progress, with DLL3-Targeting Radio-DARPin MP0712 Phase 1 Launch Expected in 2025 GlobeNewswire October 30, 2025 IND application filed for MP0712, the Company's lead Radio-DARPin candidate targeting DLL3 and co-developed with Orano Med, with Phase 1 initiation expected before year end 2025 First patient images from MP0712